Insilico Medicine's AI-designed lung disease drug rentosertib won FDA Fast Track status in late July and is heading into Phase III, a test case for whether generative AI drug discovery can produce its first real approval.
A new AI model reads a routine biopsy slide and predicts cancer subtype, genetic mutations and survival outcomes across 32 solid tumor types at once, potentially shortcutting the wait for separate genomic testing.
Mount Sinai scientists found a druggable pocket on a cancer-related protein that AlphaFold2, AlphaFold3, Boltz-2 and molecular dynamics all missed, exposing a structural blind spot in AI-driven drug discovery.
UpDoc's FDA-cleared V1.0 platform uses a large language model to talk with type 2 diabetes patients and adjust insulin doses within physician-approved bounds, and it is now deployed at Cleveland Clinic, AHN, and UCSF, raising questions about how far generative AI should go in direct patient care.
Atlanta startup CheckWellCall has soft-launched an AI-powered daily wellness check-in call for seniors, automating structured voice conversations that flag deviations from a resident's baseline for family caregivers or senior living staff to follow up on.
As the FDA continues weighing national rules following a November 2025 advisory committee meeting, Illinois, Nevada and Utah have already enacted differing state laws on AI therapy chatbots in 2026, from outright bans to disclosure requirements, creating a fragmented compliance landscape.
HCA Healthcare and Google Cloud are piloting Nurse Handoff, a generative AI tool that standardizes shift-change patient handoffs at five hospitals, with nurses rating it accurate in over 85% of cases; the company plans to scale it to its 100,000-nurse workforce if results hold.
Temple University Hospital has fully deployed an AI insulin-dosing tool called EndoTool across its hospitals, producing a more than twofold reduction in dangerous low-blood-sugar episodes among diabetic patients while keeping nurses in the approval loop.
A Nature Communications study published August 12, 2026 by Dana-Farber and Mass General Brigham researchers found that genomic screening of newborn blood spots could flag childhood cancer risk years before diagnosis, with AI-driven variant analysis making population-scale screening feasible.
Sheba Medical Center has become the first hospital outside the U.S. to gain access to OpenAI's dedicated healthcare AI models, a deal signed in July 2026 that will bring ChatGPT Health to Israeli physicians for clinical decision support and documentation.